Detalhe da pesquisa
1.
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.
Br J Haematol
; 203(2): 264-281, 2023 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-37539479
2.
Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects.
Blood
; 138(10): 858-870, 2021 09 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34036317
3.
DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.
Blood
; 128(24): 2846-2858, 2016 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-27760760
4.
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.
Blood
; 123(24): 3832-42, 2014 Jun 12.
Artigo
Inglês
| MEDLINE | ID: mdl-24711661
5.
Single-cell transcriptomics reveal different maturation stages and sublineage commitment of human thymic invariant natural killer T cells.
J Leukoc Biol
; 115(2): 401-409, 2024 01 19.
Artigo
Inglês
| MEDLINE | ID: mdl-37742056
6.
ROCK1/2 signaling contributes to corticosteroid-refractory acute graft-versus-host disease.
Nat Commun
; 15(1): 446, 2024 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38199985
7.
Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD.
Blood Adv
; 5(11): 2528-2538, 2021 06 08.
Artigo
Inglês
| MEDLINE | ID: mdl-34100904
8.
Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.
Bone Marrow Transplant
; 56(4): 909-916, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33203951
9.
Allogeneic CAR Invariant Natural Killer T Cells Exert Potent Antitumor Effects through Host CD8 T-Cell Cross-Priming.
Clin Cancer Res
; 27(21): 6054-6064, 2021 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34376537
10.
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Front Immunol
; 11: 614250, 2020.
Artigo
Inglês
| MEDLINE | ID: mdl-33488624
11.
Activation of the DR3-TL1A Axis in Donor Mice Leads to Regulatory T Cell Expansion and Activation With Reduction in Graft-Versus-Host Disease.
Front Immunol
; 10: 1624, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31379829
12.
Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation.
Front Immunol
; 8: 900, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28824628